Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: where we stand and where we go-Reference-Cited by-同舟云学术

Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: where we stand and where we go

Author:

Gevaert Thomas¹²³,Cimadamore Alessia⁴,Eckstein Markus⁵,Scarpelli Marina⁴,Lopez-Beltran Antonio⁶,Cheng Liang⁷,Montironi Rodolfo⁴

Affiliation:

1. Department of Urology, UZ Leuven, Leuven, Belgium

2. Organ Systems, Department of Development and Regeneration, KU Leuven, Leuven, Belgium

3. Department of Pathology, AZ Klina, Brasschaat, Belgium

4. Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy

5. Department of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

6. Department of Surgery, Cordoba University Medical School, Cordoba, Spain

7. Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

Reference32 articles.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Tumors of the Urinary Bladder;Tumors of the Kidney, Bladder, and Related Urinary Structures;2021-11